SCHEMBL241401

SCHEMBL241401

C/N=C(\C)c1ccccn1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.70
ALDH1A1 P00352 2/20 0.57
TOP2A P11388 2/20 0.53
RAB9A P51151 5/20 0.50
SMN1; SMN2 Q16637 5/20 0.50
MEN1 O00255 3/20 0.50
MAPT P10636 3/20 0.50
KMT2A Q03164 3/20 0.50
GAA P10253 2/20 0.50
CES2 O00748 1/20 0.50
CES1 P23141 1/20 0.50
ALOX12 P18054 1/20 0.50
GFER P55789 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
LMNA P02545 4/20 0.48
L3MBTL1 Q9Y468 3/20 0.48
NAPRT Q6XQN6 1/20 0.48
P4HTM Q9NXG6 1/20 0.48
NPC1 O15118 5/20 0.47
AGTR1 P30556 4/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19386605 1.00 KDM4E (0.70) KDM4EALDH1A1TOP2ARAB9ASMN1; SMN2
SCHEMBL167986 1.00 KDM4E (0.70) KDM4EALDH1A1TOP2ARAB9ASMN1; SMN2
SCHEMBL1256130 0.84 KDM4E (0.73) KDM4EALDH1A1TOP2ARAB9ASMN1; SMN2
SCHEMBL3660657 0.83 KDM4E (1.00) KDM4EALDH1A1TOP2ARAB9ASMN1; SMN2
SCHEMBL1384556 0.83 KDM4E (1.00) KDM4EALDH1A1TOP2ARAB9ASMN1; SMN2
SCHEMBL25162057 0.81 KDM4E (0.68) KDM4EALDH1A1TOP2ARAB9ASMN1; SMN2
SCHEMBL17963025 0.81 KDM4E (0.68) KDM4EALDH1A1TOP2ARAB9ASMN1; SMN2
SCHEMBL9768928 0.81 KDM4E (0.68) KDM4EALDH1A1TOP2ARAB9ASMN1; SMN2
SCHEMBL31494657 0.81 KDM4E (0.68) KDM4EALDH1A1TOP2ARAB9ASMN1; SMN2
SCHEMBL21238884 0.80 KDM4E (0.55) KDM4EALDH1A1TOP2ARAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1363923-B1 RHODIUM AND IRIDIUM COMPLEXES MERCK PATENT GMBH (DE) 2009-04-01 EP claimed
US-12635401-B2 Metal complexes UDC Ireland (IE) 2026-05-19 US disclosed
US-20260070936-A1 METAL COMPLEXES UDC IRELAND LTD (IE) 2026-03-12 US disclosed
EP-4069709-B1 METAL COMPLEXES UDC IRELAND LTD (IE) 2025-04-23 EP disclosed
US-12250871-B2 Metal complexes UDC IRELAND LIMITED (IE) 2025-03-11 US disclosed
US-20240260448-A1 Metal Complexes UDC IRELAND LIMITED (IE) 2024-08-01 US disclosed
US-11917901-B2 Metal complexes UDC IRELAND LIMITED (IE) 2024-02-27 US disclosed
US-20230056324-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2023-02-23 US disclosed
US-11404649-B2 Electroluminescent bridged metal complexes for use in electronic devices MERCK PATENT GMBH (DE) 2022-08-02 US disclosed
US-20220209141-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2022-06-30 US disclosed
US-7498398-B2 Thermoplastic composition, method of making, and articles formed therefrom SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2009-03-03 US disclosed
US-20080228012-A1 Reducing esters or lactones with hydrogen gas in presence of ruthenium catalyst; high yield and high catalytic efficiency under an industrially advantageous condition of relatively low hydrogen pressure and low reaction temperature TAKASAGO INTERNATIONAL CORPORATION 2008-09-18 US disclosed
US-20080027220-A1 Metal Complexes MERCK PATENT GMBH (DE) 2008-01-31 US disclosed
US-20070225470-A1 Thermoplastic composition, method of making, and articles formed therefrom SABIC GLOBAL TECHNOLOGIES IP B.V. (NL) 2007-09-27 US disclosed
US-20070219330-A1 Amide initiators WARWICK EFFECT POLYMERS LIMITED (GB) 2007-09-20 US disclosed
US-7247761-B2 Method for the production of aryl-aryl coupled compounds MERCK PATENT GMBH (DE) 2007-07-24 US disclosed
EP-1537161-B1 METHOD FOR THE PRODUCTION OF ARYL-ARYL COUPLED COMPOUNDS COVION ORGANIC SEMICONDUCTORS (DE) 2006-03-29 EP disclosed
US-20060058524-A1 Method for the production of aryl-aryl coupled compounds COVION ORGANIC SEMICONDUCTORS GMBH (DE) 2006-03-16 US disclosed
EP-1537161-A1 METHOD FOR THE PRODUCTION OF ARYL-ARYL COUPLED COMPOUNDS Covion Organic Semiconductors GmbH (DE) 2005-06-08 EP disclosed
WO-2004022626-A1 METHOD FOR THE PRODUCTION OF ARYL-ARYL COUPLED COMPOUNDS COVION ORGANIC SEMICONDUCTORS GMBH (DE) 2004-03-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260070936-A1 METAL COMPLEXES SCO2, CBR1, CORO1C KDM4E 4498/4885ALDH1A1 2087/4885TOP2A 3872/4885
US-12635401-B2 Metal complexes SCO2, SOD1, NR4A1 KDM4E 3445/4885ALDH1A1 2069/4885TOP2A 2604/4885
US-12250871-B2 Metal complexes AP1M1, SOD1, AP3M1 KDM4E 3628/4885ALDH1A1 3790/4885TOP2A 4088/4885
US-20230056324-A1 METAL COMPLEXES MCU, IMMT, SOD1 KDM4E 4474/4885ALDH1A1 1713/4885TOP2A 2545/4885
US-20080228012-A1 Reducing esters or lactones with hydrogen gas in presence of ruthenium catalyst; high yield and high catalytic efficiency under an industrially advantageous condition of relatively low hydrogen pressure and low reaction temperature LPXN, LIPE, MLX KDM4E 2963/4885ALDH1A1 1512/4885TOP2A 4285/4885
US-11404649-B2 Electroluminescent bridged metal complexes for use in electronic devices MCOLN2, MCOLN1, NCLN KDM4E 4201/4885ALDH1A1 1380/4885TOP2A 3174/4885
US-20080027220-A1 Metal Complexes AP1M1, SOD1, AP1G1 KDM4E 3323/4885ALDH1A1 363/4885TOP2A 3240/4885
US-20220209141-A1 METAL COMPLEXES AP1M1, SOD1, AP3M1 KDM4E 3628/4885ALDH1A1 3790/4885TOP2A 4088/4885
US-20060058524-A1 Method for the production of aryl-aryl coupled compounds TYR, AHR, ARSA KDM4E 1022/4885ALDH1A1 366/4885TOP2A 4205/4885
US-11917901-B2 Metal complexes MCOLN2, MCOLN1, AP1M1 KDM4E 4260/4885ALDH1A1 1631/4885TOP2A 3261/4885
US-20240260448-A1 Metal Complexes SOD1, AP1M1, AP3M1 KDM4E 3816/4885ALDH1A1 3721/4885TOP2A 3772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.